Kenichi Morikawa

22PUBLICATIONS
8CO-AUTHORS
Metabolic medicineHaematologyPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsNeurosciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 15, 2026
Selective PPARα Modulator Pemafibrate Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Regulation of Leptin Signaling and Remodeling of Gut Microbiota.

|Aug 29, 2022
Incidence of post-transplant hepatitis B virus reactivation with the use of kidneys from donors with resolved hepatitis B virus infection.

Ren Yamada, Kenichi Morikawa, Kiyohiko Hotta

|Mar 30, 2022
Overestimated renal function in patients with liver cirrhosis predicts poor prognosis.

Sonoe Yoshida, Goki Suda, Masatsugu Ohara

|Mar 30, 2022
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.

Machiko Umemura, Koji Ogawa, Kenichi Morikawa

|Feb 07, 2022
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.

Akihisa Nakamura, Koji Yamamoto, Rei Takeda

|Jul 10, 2021
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.

Takuya Sho, Goki Suda, Koji Ogawa

Pageof 4

Frequent Collaborators

14 joint publications

Goki Suda

12 joint publications

Naoki Kawagishi

3 joint publications

Koji Ogawa

1 joint publications

Hiroyoshi Doi